Mankind Pharma files Draft Red Herring Prospectus with SEBI

Mankind Pharma Limited has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI). The firm's initial public offering comprises an offer for sale of 40,058,884 equity shares of face value ₹1 each by selling shareholders including the promoters and existing investors.

The offer for sale comprises of up to 3,705,443 equity shares by Ramesh Juneja, up to 3,505,149 equity shares by Rajeev Juneja, up to 2,804,119 equity shares by Sheetal Arora (Collectively: the promoter selling shareholders), up to 17,405,559 equity shares by Cairnhill CIPEF Limited, up to 2,623,863 equity shares by Cairnhill CGPE Limited, up to 9,964,711 equity shares by Beige Limited and up to 50,000 equity shares by Link Investment Trust (Collectively: the investor selling shareholders). Kotak Mahindra Capital Company Limited, Axis Capital Limited, IIFL Securities Limited, Jefferies India Private Limited and JP Morgan India Private Limited are the Book Running Lead Managers to the issue.